136 related articles for article (PubMed ID: 31471646)
1. Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass.
Iepsen EW; Zhang J; Hollensted M; Madsbad S; Hansen T; Holst JJ; Jørgensen NR; Holm JC; Torekov SS
J Bone Miner Metab; 2020 Jan; 38(1):117-125. PubMed ID: 31471646
[TBL] [Abstract][Full Text] [Related]
2. Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.
Iepsen EW; Zhang J; Thomsen HS; Hansen EL; Hollensted M; Madsbad S; Hansen T; Holst JJ; Holm JC; Torekov SS
Cell Metab; 2018 Jul; 28(1):23-32.e3. PubMed ID: 29861388
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report.
Iepsen EW; Have CT; Veedfald S; Madsbad S; Holst JJ; Grarup N; Pedersen O; Brandslund I; Holm JC; Hansen T; Torekov SS
Cell Rep Med; 2020 Apr; 1(1):100006. PubMed ID: 33205056
[TBL] [Abstract][Full Text] [Related]
4. The role of polygenic susceptibility to obesity among carriers of pathogenic mutations in MC4R in the UK Biobank population.
Chami N; Preuss M; Walker RW; Moscati A; Loos RJF
PLoS Med; 2020 Jul; 17(7):e1003196. PubMed ID: 32692746
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating.
Lubrano-Berthelier C; Dubern B; Lacorte JM; Picard F; Shapiro A; Zhang S; Bertrais S; Hercberg S; Basdevant A; Clement K; Vaisse C
J Clin Endocrinol Metab; 2006 May; 91(5):1811-8. PubMed ID: 16507637
[TBL] [Abstract][Full Text] [Related]
6. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.
Rettenbacher E; Tarnow P; Brumm H; Prayer D; Wermter AK; Hebebrand J; Biebermann H; Hinney A; Widhalm K
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):7-12. PubMed ID: 17286227
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis.
Hainerová I; Larsen LH; Holst B; Finková M; Hainer V; Lebl J; Hansen T; Pedersen O
J Clin Endocrinol Metab; 2007 Sep; 92(9):3689-96. PubMed ID: 17579204
[TBL] [Abstract][Full Text] [Related]
8. Relationships of acylated and des-acyl ghrelin levels to bone mineralization in obese children and adolescents.
Pacifico L; Anania C; Poggiogalle E; Osborn JF; Prossomariti G; Martino F; Chiesa C
Bone; 2009 Aug; 45(2):274-9. PubMed ID: 19393347
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
[TBL] [Abstract][Full Text] [Related]
10. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
[TBL] [Abstract][Full Text] [Related]
11. Apparent bone mineral density estimated from DXA in healthy men and women.
Cvijetić S; Korsić M
Osteoporos Int; 2004 Apr; 15(4):295-300. PubMed ID: 14628108
[TBL] [Abstract][Full Text] [Related]
12. Influence of orlistat on bone turnover and body composition.
Gotfredsen A; Westergren Hendel H; Andersen T
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1154-60. PubMed ID: 11486790
[TBL] [Abstract][Full Text] [Related]
13. Relationship between body composition and bone mass in women.
Khosla S; Atkinson EJ; Riggs BL; Melton LJ
J Bone Miner Res; 1996 Jun; 11(6):857-63. PubMed ID: 8725184
[TBL] [Abstract][Full Text] [Related]
14. Growth and bone health in pediatric intestinal failure patients receiving long-term parenteral nutrition.
Pichler J; Chomtho S; Fewtrell M; Macdonald S; Hill SM
Am J Clin Nutr; 2013 Jun; 97(6):1260-9. PubMed ID: 23576042
[TBL] [Abstract][Full Text] [Related]
15. Body composition and bone metabolism in young Gaucher disease type I patients treated with imiglucerase.
Parisi MS; Mastaglia SR; Bagur A; Goldstein G; Zeni SN; Oliveri B
Eur J Med Res; 2008 Jan; 13(1):31-8. PubMed ID: 18226995
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents.
Misra M; Miller KK; Stewart V; Hunter E; Kuo K; Herzog DB; Klibanski A
J Clin Endocrinol Metab; 2005 Sep; 90(9):5082-7. PubMed ID: 15998770
[TBL] [Abstract][Full Text] [Related]
17. [PHASIC CHANGES OF BONE MASS, BONE TURNOVER MARKERS, AND ESTROGEN LEVELS AT DIFFERENT TIME POINTS AFTER GLUCOCORTICOID INTERVENTION AND THEIR CORRELATION IN RATS].
Ren H; Shen G; Jiang X; Liang D; Tang J; Cui J; Lin S; Zhuang H; Yang Z; Zhang S; Yao Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Mar; 29(3):307-14. PubMed ID: 26455196
[TBL] [Abstract][Full Text] [Related]
18. How does body fat influence bone mass in childhood? A Mendelian randomization approach.
Timpson NJ; Sayers A; Davey-Smith G; Tobias JH
J Bone Miner Res; 2009 Mar; 24(3):522-33. PubMed ID: 19016587
[TBL] [Abstract][Full Text] [Related]
19. Turner syndrome adolescents receiving growth hormone are not osteopenic.
Neely EK; Marcus R; Rosenfeld RG; Bachrach LK
J Clin Endocrinol Metab; 1993 Apr; 76(4):861-6. PubMed ID: 8473397
[TBL] [Abstract][Full Text] [Related]
20. Effect of bone area on spine density in Chinese men and women in Taiwan.
Tsai KS; Cheng WC; Chen CK; Sanchez TV; Su CT; Chieng PU; Yang RS
Bone; 1997 Dec; 21(6):547-51. PubMed ID: 9430246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
